Oncotherapeutics Incorporated Pages on BioPortfolio:

BioPortfolio - Oncotherapeutics Inc
Oncotherapeutics Inc - BioPortfolio. ... Oncotherapeutics Incorporated · One Cell Systems Incorporated ... Orphan Pharmaceuticals USA Inc · Orphan ...
http://www.bioportfolio.com/search/Oncotherapeutics_Inc.html...

BioPortfolio - Biocorporate Search
Oncormed, Inc. is a genomics services company that characterizes newly discovered genes to establish their medical ... Oncotherapeutics Incorporated
...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

Pharmaceutical, Life Science, Medical, Biotechnology, Healthcare ...
Oncotherapeutics Incorporated · One Cell Systems Incorporated · One Lambda Incorporated · Ono Pharma USA · Ono Pharmaceutical Company Limited ...
http://www.bioportfolio.com/biotechnology/BioCorporate_Direc...

BioPortfolio - paradigm thera
PanBio Pty Limited · Paradigm Medical Industries, Inc. Paramedical S.r.l. ... Avenue Extension | oncotherapeutics | paradigm thera | University of Erlangen
...
http://www.bioportfolio.com/search/paradigm_thera.html...

BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...

Results from other life science and pharmaceutical sites:

Phase I/II trial assessing bortezomib and melphala...[J Clin Oncol ...
Oncotherapeutics Inc, West Hollywood, CA, USA. jberenson@myelomasource.org. PURPOSE: Bortezomib has shown synergy with melphalan in preclinical models. ...
http://www.ncbi.nlm.nih.gov/pubmed/16418495...

A phase I/II study of arsenic trioxide/bortezomib/...[Clin Cancer ...
Institute for Myeloma and Bone Cancer Research and Oncotherapeutics Inc, West Hollywood, CA 90069, USA. jberenson@imbcr.org ...
http://www.ncbi.nlm.nih.gov/pubmed/17363530...

Stress proteins in Alzheimer's disease. [Int J Hyperthermia. 2005 ...
New England OncoTherapeutics Inc., Cambridge, MA 02142, USA. rcsmith@newonc.com. Environmental and genetic conditions can cause proteins to misfold or to ...
http://www.ncbi.nlm.nih.gov/pubmed/16048839...

Changes in Expression of Signal Transduction Proteins in T ...
The membranes were immunoblotted with anti-ζ-chain antiserum (Onco-Zeta 1; Biomira USA [previously Onco Therapeutics Inc.], Cranbury, N.J.) and anti-human
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...

Prostate Cancer and Prostatic Diseases - Immunohistochemical ...
... USA and by a University-Industry grant from the Natural Sciences and Engineering Research Council of Canada and ONCOTherapeutics Inc. ...
http://www.nature.com/pcan/journal/v6/n3/full/4500674a.html...

News: Abraxis BioScience and Biocon Limited Announce Licensing ...
19 Jul 2007 ... general manager, Business Development & Oncotherapeutics SBU Head, Biocon Limited. ... Abraxis BioScience, Inc. is an integrated global ...
http://www.genengnews.com/news/bnitem.aspx?name=20522839...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.